肺がん治療ワクチンの世界市場及びパイプラインインサイト

調査会社KuicK Research社が発行したリサーチレポート(データ管理コード:KUCK502261)
◆英語タイトル:Global Lung Cancer Vaccine Market & Pipeline Insight 2015
◆発行会社/調査会社:KuicK Research
◆商品コード:KUCK502261
◆発行日:2015年2月
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,200 ⇒換算¥135,600見積依頼/購入/質問フォーム
Multi User(全社内共有可)USD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
KuicK Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[肺がん治療ワクチンの世界市場及びパイプラインインサイト]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Lung cancer incidences are rapidly increasing and various therapeutics have been introduced in global market to provide better care to patients. Surgery and radiation therapy are not preferred for lung cancer treatment due to which they have small global market size. Chemotherapeutics and targeted therapeutics for lung cancer treatment are major market contender in global market with wide acceptance levels among oncologists and patients. Chemotherapeutics have life threatening side effects while targeted therapeutics available in markets are quite effective therapeutics but they are unable to reduce the present lung cancer mortality rates. These drawbacks are not expected to be associated with lung cancer vaccines which will help in generating significant revenues and increased penetration across the globe.

Identification of novel targets for lung cancer vaccine development is underway by pharmaceutical companies to provide efficient medical care to patients. Many mechanisms and tumour antigen has been identified for the development of novel lung cancer vaccines. Different lung cancer vaccines will help the patients in deciding better therapeutic options and generate significant revenues for pharmaceutical companies. Pharmacological effects provided by these novel lung cancer vaccine is expected to help the lung cancer patients across the globe.

Melanoma associated antigen 3(MAGE-3) is target of various cancer vaccines for therapeutic treatment of lung cancer. This antigen is absent in normal cell, while it is abundantly found in cancerous cells making it a suitable candidate for developing lung cancer vaccine targeting different stages of cancer progression. These lung cancer vaccines are able to identify different levels of MAGE-3 leading to their correct identification. As a result, cancer vaccine targeting this antigen is expected to have minimized side effects because it is absent in normal cell. This fact also shows that relapse may not occur due to eradication of all existing cancerous cells from the body.

Lung cancer vaccine is formulated by incorporating MAGE-3 antigen as source of activation for immune cells. This vaccine consists of fusion between human MAGE-3 antigen and protein D from Haemophilus influnzae. When it is injected inside the body it causes the immune system to get activated and identify this formulation as external entity. This causes the memory cells to search for any external substances in body having signature sequences like vaccines. As a result, cancerous cells present in the body are identified as external entity and selectively eliminated to prevent the cancer progression.

Lung cancer vaccines are expected to become a major tool in lung cancer treatment in coming years due to superior pharmacological performance. Prophylactic lung cancer vaccines are needed to be developed and thoroughly investigated in clinical trilas. Many innovative lung cancer vaccines are under various phases of clinical trials effective medical treatment. Significant clinical data generated has given encouragement to oncologists and pharmaceutical companies to investigate different forms of lung cancer vaccine. These vaccines are under investigation, once high safety and efficacy levels are obtained then it would be easy to apply for the marketing approval across the globe in various countries.

“Global Lung Cancer Vaccine Market & Pipeline Insight 2015” Report Highlights:
• Introduction to Lung Cancer Vaccine
• Global Lung Cancer Vaccine Market Analysis
• Global Lung Cancer Vaccine Pipeline by Company & Phase
• Global Lung Cancer Vaccine Pipeline: 29 Vaccines
• Majority Lung Cancer Vaccines in Phase-II: 8 Vaccines
• Marketed Lung Cancer Vaccines: 3 ( BV NSCLC 001, Mycidac-C & Vaxira)
• Personalized Cancer Vaccines: Progress & Possibilities
• Lung Cancer Vaccine Mechanism

*** レポート目次(コンテンツ)***

1. Introduction to Cancer Vaccines

2. Cancer Vaccines: Mechanism & Innovations
2.1 Idiotype Cancer Vaccine Mechanism
2.2 Cellular Cancer Vaccines Mechanism
2.3 Ganglioside Antigens based Cancer Vaccines Mechanism
2.4 Peptide Cancer Vaccine Mechanism
2.5 Tumor Host Interaction Cancer Vaccine Mechanism

3. Introduction Global Lung Cancer Vaccine

4. Mechanism of Lung Cancer Vaccines

5. Global Lung Cancer Vaccine Market Outlook
5.1 Current Market Scenario
5.2 Global Lung Cancer Vaccines Pipeline Overview

6. Global Lung Cancer Market Dynamics
6.1 Favorable Market Parameters
6.2 Market & Commercialization Challenges

7. Global Lung Cancer Vaccine Market Future Prospects

8. Global Lung Cancer Vaccine Pipeline by Company & Phase
8.1 Preclinical
8.2 Clinical
8.3 Phase-I
8.4 Phase-I/II
8.5 Phase-II
8.6 Phase-II/III
8.7 Phase-III

9. Marketed Lung Cancer Vaccine Clinical Insight
9.1 BV NSCLC 001
9.2 Mycidac-C™
9.3 Vaxira®

10. Suspended & Discontinued Lung Cancer Vaccines Pipeline by Company & Phase
10.1 No Development Reported
10.2 Discontinued

11. Competitive Landscape
11.1 Boehringer Ingelheim
11.2 CureVac
11.3 Eli Lily
11.4 Galaxo
11.5 ImClone Systems
11.6 Merck
11.7 Ono Pharmaceutical
11.8 Oncothyreon Incorporation

Figure 1-1: Categorization & Function of Cancer Vaccines
Figure 2-1: Classification of Different Types of Cancer vaccines
Figure 3-1: Functions of Lungs
Figure 3-2: Factors Responsible for Increasing Lung Cancer Incidences
Figure 4-1: Type of Lung Cancer
Figure 4-2: Types of Lung Cancer Treatment
Figure 4-3: Mechanism of MAGE-3 Lung Cancer Vaccine
Figure 4-4: Mechanism of p53 Lung Cancer Vaccine
Figure 4-5: Mechanism of NY-ESO-1 Lung Cancer Vaccine
Figure 5-1: Global Lung Cancer Vaccines Pipeline (%), 2015
Figure 5-2: Global Lung Cancer Vaccines Pipeline (Number), 2015
Figure 5-3: No Development Reported in Lung Cancer Vaccines Pipeline (%), 2015
Figure 5-4: No Development Reported in Lung Cancer Vaccines Pipeline (Number), 2015
Figure 5-5: Discontinued Lung Cancer Vaccines Pipeline (%), 2015
Figure 5-6: Discontinued Lung Cancer Vaccines Pipeline (Number), 2015
Figure 6-1: Drivers for Lung Cancer Vaccines
Figure 6-2: Market & Commercialization Challenges


*** 掲載企業 ***

Boehringer Ingelheim, CureVac, Eli Lily, Galaxo, ImClone Systems, Merck, Ono Pharmaceutical, Oncothyreon Incorporation

*** レポートのキーワード ***

肺がんワクチン、治験、治療薬、パイプライン、化学療法

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • Evans Bancorp Inc. (EVBN):企業概要及び分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Evans Bancorp Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligenc …
  • 世界のスポーツおよびフィットネス服市場2016
    Notes:Production, means the output of Sports and Fitness Clothing Revenue, means the sales value of Sports and Fitness Clothing This report studies Sports and Fitness Clothing in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers …
  • USAIG – McCleary Steel Pipe Manufacturing Plant – Washington – 建設プロジェクト概要
    WMI's USAIG - McCleary Steel Pipe Manufacturing Plant - Washington - Construction Project Profile is a crucial resource for industry executives and anyone looking to access key information about the McCleary Steel Pipe Manufacturing Plant construction project. WMI's USAIG - McCleary Steel Pipe Manuf …
  • スウェーデンの塗料・ワニス市場(~2019)
    The industry report Paint and Varnish Market in Sweden to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for paints and varnishes in Sweden. The research includes historic market data from 2008 to 2014 and fore …
  • 金属除去液の世界市場2016-2020
    About Removal Fluids Removal fluids are categorized as lubricant or coolants fabricated particularly for metalworking processes, including stamping and machining. There are different sub-segments of removal fluids include oils, oil-water emulsions, air, aerosols (mists), pastes, gels, and gases. Rem …
  • ソーダ灰の世界市場動向及び予測2015
    The present report is an essential resource for a one looking for detailed information on the world soda ash market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analyt …
  • 調味料ソース市場(~2017):ブルガリア
    Synopsis The report presents detailed data on consumption trends in the Condiment Sauces category in Bulgaria, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels along with latest industry news and mergers and acquisitions (of Seas …
  • Growth Technologies, Inc.:企業SWOT分析(IT・通信業界)
    Summary This comprehensive SWOT profile of Growth Technologies, Inc. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and t …
  • Masco Corporation (MAS) : 企業概要及びSWOT分析
    This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business. WMI's 'Masco Corporation (MAS) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which a …
  • シングル2価抗体の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Single Bivalent Antibodies Revenue, means the sales value of Single Bivalent Antibodies This report studies sales (consumption) of Single Bivalent Antibodies in Global market, especially in United States, China, Europe and Japan, focuses on top players in these …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(KUCK502261 )"肺がん治療ワクチンの世界市場及びパイプラインインサイト" (英文:Global Lung Cancer Vaccine Market & Pipeline Insight 2015)はKuicK Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。